Timothy D. McHugh

20.9k total citations · 7 hit papers
234 papers, 9.0k citations indexed

About

Timothy D. McHugh is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Timothy D. McHugh has authored 234 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 149 papers in Infectious Diseases, 130 papers in Epidemiology and 47 papers in Molecular Biology. Recurrent topics in Timothy D. McHugh's work include Tuberculosis Research and Epidemiology (132 papers), Mycobacterium research and diagnosis (86 papers) and Antibiotic Resistance in Bacteria (36 papers). Timothy D. McHugh is often cited by papers focused on Tuberculosis Research and Epidemiology (132 papers), Mycobacterium research and diagnosis (86 papers) and Antibiotic Resistance in Bacteria (36 papers). Timothy D. McHugh collaborates with scholars based in United Kingdom, United States and Germany. Timothy D. McHugh's co-authors include Stephen H. Gillespie, Alimuddin Zumla, Ibrahim Abubakar, Marc Lipman, Owen Billington, Matthew Bates, Patrick Phillips, Andrew Nunn, Angela M. Crook and Carl M. Mendel and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Timothy D. McHugh

222 papers receiving 8.8k citations

Hit Papers

Global Tuberculosis Report 2020 ... 2013 2026 2017 2021 2021 2020 2014 2013 2018 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Global Tuberculosis Report 2020 – Reflections on the Global TB burden, treatment and prevention efforts
    2021 673 citations Timothy D. McHugh, Ibrahim Abubakar et al. International Journal of Infectious Diseases profile →
  2. Treatment of Highly Drug-Resistant Pulmonary Tuberculosis
    2020 585 citations Andreas H. Diacon, Timothy D. McHugh et al. profile →
  3. Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis
    2014 401 citations Stephen H. Gillespie, Timothy D. McHugh et al. profile →
  4. Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test
    2013 356 citations Timothy D. McHugh, Ibrahim Abubakar et al. profile →
  5. Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies
    2018 271 citations Timothy D. McHugh, Alimuddin Zumla et al. profile →
  6. Tuberculosis: advances and challenges in development of new diagnostics and biomarkers
    2018 242 citations Timothy D. McHugh, Alimuddin Zumla et al. profile →
  7. A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis
    2022 154 citations Timothy D. McHugh et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Timothy D. McHugh United Kingdom 48 5.7k 4.5k 2.0k 1.9k 815 234 9.0k
Stephen H. Gillespie United Kingdom 52 6.0k 1.0× 5.4k 1.2× 1.7k 0.9× 1.8k 0.9× 1.1k 1.3× 263 10.2k
Véronique Dartois United States 56 6.6k 1.1× 4.7k 1.0× 3.8k 1.9× 1.6k 0.8× 900 1.1× 202 10.2k
Emmanuelle Cambau France 46 4.5k 0.8× 5.0k 1.1× 2.2k 1.1× 1.3k 0.7× 1.7k 2.0× 148 8.3k
Eric L. Nuermberger United States 51 6.6k 1.1× 4.6k 1.0× 2.5k 1.2× 1.4k 0.7× 878 1.1× 169 8.1k
Heiman Wertheim Netherlands 50 6.0k 1.0× 3.1k 0.7× 2.7k 1.3× 1.0k 0.5× 1.4k 1.7× 218 12.3k
David Alland United States 52 8.4k 1.5× 7.0k 1.5× 3.4k 1.7× 3.3k 1.7× 895 1.1× 135 11.7k
Brunella Posteraro Italy 58 6.0k 1.1× 5.1k 1.1× 2.0k 1.0× 487 0.3× 1.0k 1.2× 281 10.3k
Gail L. Woods United States 44 5.1k 0.9× 5.6k 1.2× 800 0.4× 1.8k 0.9× 705 0.9× 196 8.8k
J Grosset France 58 7.9k 1.4× 7.2k 1.6× 2.3k 1.1× 2.6k 1.4× 1.1k 1.3× 258 10.5k
Giovanni Battista Migliori Italy 65 10.2k 1.8× 7.4k 1.7× 1.7k 0.8× 4.3k 2.3× 449 0.6× 351 13.7k

Countries citing papers authored by Timothy D. McHugh

Since Specialization
Citations

This map shows the geographic impact of Timothy D. McHugh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy D. McHugh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy D. McHugh more than expected).

Fields of papers citing papers by Timothy D. McHugh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy D. McHugh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy D. McHugh. The network helps show where Timothy D. McHugh may publish in the future.

Co-authorship network of co-authors of Timothy D. McHugh

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy D. McHugh. A scholar is included among the top collaborators of Timothy D. McHugh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy D. McHugh. Timothy D. McHugh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heinrich, Norbert, Veronique de Jager, Patrick Phillips, et al.. (2025). Population pharmacokinetics and exposure–response relationship of the antituberculosis drug BTZ-043. Journal of Antimicrobial Chemotherapy. 80(5). 1315–1323. 1 indexed citations
2.
Huggett, Jim F., Denise M. O’Sullivan, Katell Peoc’h, et al.. (2025). An assessment of molecular diagnosis of tuberculosis and multi-drug resistant tuberculosis testing and quality assessment: findings of an international survey. Clinical Chemistry and Laboratory Medicine (CCLM). 63(11). 2341–2347.
3.
Maitra, Arundhati, et al.. (2024). The impact of physiological state and environmental stress on bacterial load estimation methodologies for Mycobacterium tuberculosis. Scientific Reports. 14(1). 26108–26108. 1 indexed citations
4.
Billington, Owen, Stephen Morris‐Jones, James Millard, et al.. (2024). Acetic Acid Enables Molecular Enumeration of Mycobacterium tuberculosis from Sputum and Eliminates the Need for a Biosafety Level 3 Laboratory. Clinical Chemistry. 70(4). 642–652.
5.
Asif, Amina, Khalid Mahmood, Saba Riaz, Timothy D. McHugh, & Sikander Sultan. (2023). Bacterial ventriculoperitoneal shunt infections: changing trends in antimicrobial susceptibility, a 7-year retrospective study from Pakistan. Antimicrobial Resistance and Infection Control. 12(1). 75–75. 5 indexed citations
6.
Lee, Seung Heon, Adam A. Witney, Hyungseok Kang, et al.. (2023). A comparison of phenotypic and WGS drug susceptibility testing in Mycobacterium tuberculosis isolates from the Republic of Korea. JAC-Antimicrobial Resistance. 5(3). dlad056–dlad056. 2 indexed citations
7.
Evangelopoulos, Dimitrios, Carolyn Shoen, Isobella Honeyborne, et al.. (2022). Culture-Free Enumeration of Mycobacterium tuberculosis in Mouse Tissues Using the Molecular Bacterial Load Assay for Preclinical Drug Development. Microorganisms. 10(2). 460–460. 4 indexed citations
8.
Gurusamy, Kurinchi Selvan, David Moher, Marilena Loizidou, et al.. (2021). Clinical relevance assessment of animal preclinical research (RAA) tool: development and explanation. PeerJ. 9. e10673–e10673. 9 indexed citations
9.
Yavlinsky, Alexei, et al.. (2020). Mobile-based and open-source case detection and infectious disease outbreak management systems: a review [version 1; peer review: awaiting peer review]. UCL Discovery (University College London). 1 indexed citations
10.
Story, Alistair, Elizabeth Garber, Robert W Aldridge, et al.. (2020). Management and control of tuberculosis control in socially complex groups: a research programme including three RCTs. SHILAP Revista de lepidopterología. 8(9). 1–76. 5 indexed citations
11.
Honeyborne, Isobella, Marc Lipman, Alimuddin Zumla, & Timothy D. McHugh. (2019). The changing treatment landscape for MDR/XDR-TB — Can current clinical trials revolutionise and inform a brave new world?. International Journal of Infectious Diseases. 80. S23–S28. 20 indexed citations
12.
McHugh, Timothy D., et al.. (2018). Detection of carbapenemases, AmpC and ESBL genes in Acinetobacter isolates from ICUs by DNA microarray. Journal of Microbiological Methods. 155. 19–23. 19 indexed citations
13.
Guzman, Juan, Dimitrios Evangelopoulos, Antima Gupta, et al.. (2013). Antitubercular specific activity of ibuprofen and the other 2-arylpropanoic acids using the HT-SPOTi whole-cell phenotypic assay. BMJ Open. 3(6). e002672–e002672. 68 indexed citations
14.
Donaldson, Gavin C., et al.. (2013). Impact Of Antibiotic Exposure On The Development Of Antibiotic Resistance In COPD Patients. American Journal of Respiratory and Critical Care Medicine. 1 indexed citations
15.
Bryant, Josephine M., Simon R. Harris, Julian Parkhill, et al.. (2013). Whole-genome sequencing to establish relapse or re-infection with Mycobacterium tuberculosis: a retrospective observational study. The Lancet Respiratory Medicine. 1(10). 786–792. 153 indexed citations
16.
McHugh, Timothy D., et al.. (2010). Radiological cavitation, sputum mycobacterial load and treatment response in pulmonary tuberculosis. UCL Discovery (University College London). 38 indexed citations
17.
Islam, Johirul, et al.. (2005). Messenger RNA as a marker of treatment response in pulmonary tuberculosis. UCL Discovery (University College London). 1 indexed citations
18.
Shorten, RJ, et al.. (2004). Is there an association between paradoxical reactions and mycobacterium tuberculosis strain type?. UCL Discovery (University College London). 1 indexed citations
19.
McHugh, Timothy D.. (2002). The Growth of Person-to-Person Electronic Payments. Chicago Fed Letter. 1. 3 indexed citations
20.
Kent, Lindsey, et al.. (1995). DEMONSTRATION OF HOMOLOGY BETWEEN IS6110 OF MYCOBACTERIUM-TUBERCULOSIS AND DNAS OF OTHER MYCOBACTERIUM SPP (VOL 33, PG 2290, 1995). UCL Discovery (University College London). 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephen H. Gillespie Breakdown of academic impact, for papers by Véronique Dartois Breakdown of academic impact, for papers by Emmanuelle Cambau Breakdown of academic impact, for papers by Eric L. Nuermberger Breakdown of academic impact, for papers by Heiman Wertheim Breakdown of academic impact, for papers by David Alland Breakdown of academic impact, for papers by Brunella Posteraro Breakdown of academic impact, for papers by Gail L. Woods Breakdown of academic impact, for papers by J Grosset Breakdown of academic impact, for papers by Giovanni Battista Migliori
Rankless by CCL
2026